HOMA-beta
Selected indexed studies
- β-Cell Dedifferentiation in HOMA-βlow and HOMA-βhigh Subjects. (J Clin Endocrinol Metab, 2025) [PMID:39133811]
- HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors. (Front Endocrinol (Lausanne), 2024) [PMID:39722806]
- Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index. (Diabetes Metab Res Rev, 2017) [PMID:28303626]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- β-Cell Dedifferentiation in HOMA-βlow and HOMA-βhigh Subjects. (2025) pubmed
- HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors. (2024) pubmed
- Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index. (2017) pubmed
- HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not? (2009) pubmed
- Pretransplant HOMA-β Is Predictive of Insulin Independence in 7 Patients With Chronic Pancreatitis Undergoing Islet Autotransplantation. (2022) pubmed
- Should insulin resistance (HOMA-IR), insulin secretion (HOMA-β), and visceral fat area be considered for improving the performance of diabetes risk prediction models. (2024) pubmed
- Fatty acid correlations with HOMA-IR and HOMA-% β are differentially dictated by their serum free and total pools and flaxseed oil supplementation. (2023) pubmed
- Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study. (2023) pubmed
- Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study. (2015) pubmed
- Dedifferentiation as a Stealthy Disruptor of β-Cell Function in Diabetes. (2025) pubmed